Exploring the role of consanguinity in thalassemia prevalence in Pakistan: an in-depth analysis of genetic and cultural factors affecting public health
- PMID: 40851932
- PMCID: PMC12369746
- DOI: 10.1097/MS9.0000000000003404
Exploring the role of consanguinity in thalassemia prevalence in Pakistan: an in-depth analysis of genetic and cultural factors affecting public health
Abstract
Thalassemia syndromes, inherited disorders marked by reduced hemoglobin production, pose a significant global health challenge, particularly in regions with high rates of consanguineous marriages. α- and β-Thalassemia vary in severity, ranging from asymptomatic carriers to severe anemia requiring lifelong transfusions. Consanguinity, common in areas like Southeast Asia, the Mediterranean, and Africa, significantly contributes to the high prevalence of β-thalassemia in countries such as Pakistan and India, where rates can reach up to 73%. This cultural practice, deeply rooted in family ties and tradition, complicates public health efforts focused on prevention and management. Current treatment strategies rely heavily on supportive care, including regular blood transfusions and iron chelation therapy, with curative options limited by donor availability and economic constraints. Preventive efforts highlight the importance of mandatory premarital and prenatal screening, genetic counseling, and public education to reduce hereditary transmission of thalassemia. Despite progress in genomic medicine, there remain challenges in delivering comprehensive genetic services in affected regions. Addressing the complex relationship between genetic predisposition, cultural customs, and healthcare access is crucial to mitigating the prevalence and impact of thalassemia globally.
Keywords: Pakistan; consanguinity; genetic disorder; public health; thalassemia.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Beta-Thalassemia.2000 Sep 28 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2000 Sep 28 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301599 Free Books & Documents. Review.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Thalassemia in Bangladesh: progress, challenges, and a strategic blueprint for prevention.Orphanet J Rare Dis. 2025 Jul 10;20(1):358. doi: 10.1186/s13023-025-03744-x. Orphanet J Rare Dis. 2025. PMID: 40640823 Free PMC article. Review.
-
Sickle Cell Disease.2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301551 Free Books & Documents. Review.
-
Ophthalmia Neonatorum.2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31855399 Free Books & Documents.
References
-
- Thalassemia BH. U.S. National Library of Medicine. Published 2023. Accessed 11 August 2024. https://www.ncbi.nlm.nih.gov/books/NBK545151/
-
- Sadiq IZ, Abubakar FS, Usman HS, et al. Thalassemia: pathophysiology, diagnosis, and advances in treatment. Thalass Rep 2024;14:81–102.
Publication types
LinkOut - more resources
Full Text Sources